Hikma Pharmaceuticals Says Plans London IPO

LONDON, Oct 17 (Reuters) - Generic drug company Hikma Pharmaceuticals said on Monday it planned to float on the London Stock Exchange with a price range of 265 to 330 pence, the middle of which values it at about 500 million pounds ($874.9 million).